KCM
ATRS

Kennedy Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Kennedy Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,100
Closed -$44K – 763
2015
Q1 		$44K Buy
+16,100
New +$40.8K ﹤0.01% 718
2014
Q1 		– Sell
-116,279
Closed -$520K – 791
2013
Q4 		$520K Buy
+116,279
New +$474K 0.01% 694

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

Kennedy Capital Management's ATRS Position: Q2 2015 in Review

Kennedy Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2015, closing a stake of 16,100 shares — an estimated $44K sold.

Kennedy Capital Management first reported a position in ATRS in Q4 2013 and held it in 2 quarters. The position peaked at $520K in Q4 2013. 88 funds tracked by Wall St. Rank hold ATRS as of Q2 2015.

  • Kennedy Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • Kennedy Capital Management sold 16,100 Antares Pharma, Inc. shares in Q2 2015, an estimated $44K.
  • Kennedy Capital Management first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 2 quarters.
  • Kennedy Capital Management's Antares Pharma, Inc. position peaked at $520K in Q4 2013.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2015.

Based on Kennedy Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.